Industry Updates for the Psychedelics World | Page 23 of 35

Psychedelics News

Industry

10 Aug 2022

Optimi Health Launches Psilocybin Product w Patient Advocate Thomas Hartle

Optimi Health Unveils Canada’s First Natural Therapeutic Psilocybin Product For Approved Patients...

By Microdose NewsDesk

Industry

9 Aug 2022

Breaking News: Terran Biosciences Sues Compass Pathways for Stealing Trade Secrets

According to the court filings, Compass allegedly entered into negations and signed an NDA with a researcher regarding psilocybin development, before ending the talks and "milking" him for this confidential...

By Microdose NewsDesk

Finance, Industry

9 Aug 2022

Cybin Announces Financial Results and $35M Equity Program

Cybin has started the week off with several newsworthy stories....

By Microdose NewsDesk

Industry

5 Aug 2022

MindMed Announces 1:15 Reverse Stock Split

According to the press release: “The reverse share split is intended to enable the Company to achieve several important corporate objectives, give the Company greater flexibility in considering and planning...

By Microdose NewsDesk

Join Our Newsletter for Exclusive Updates, Stories, and More

Industry

29 Jul 2022

Project Solace: The World’s Largest Psilocybin Access and Data Project

The world's largest medical psilocybin access and data project set to launch, led by Canadian non-profit TheraPsil....

By Microdose

Breaking News, Industry

28 Jul 2022

Compass Pathways Launches New Phase 2 Trial for Anorexia

Today we have more positive news, with the firm announcing a new Phase 2 trial using its COMP360 psilocybin for anorexia, taking place at prestigious sites like King's College London...

By Microdose NewsDesk

Industry

26 Jul 2022

Small Pharma Granted U.S. Patent for Injectable DMT

Key U....

By Microdose NewsDesk

Industry

26 Jul 2022

Nonprofit B.More Submits Phase 2b Trial for Alcohol Use to the FDA

B....

By Microdose NewsDesk

Industry, Press Releases

25 Jul 2022

Mindbio Research Partners Receive $1.4 M Grant for Microdosing Trial

Blackhawk's Mindbio Therapeutics Announces Research Collaborators at University of Auckland Receive Grant Funding of $1....

By Microdose NewsDesk

Follow us on social

Latest News

AbbVie Withdraws Patent Challenge, Clearing Path for Enveric’s Psychedelic IP Strategy

Breaking: Enveric Reports New Mechanistic Data Supporting Non-Hallucinogenic Neuroplastogen Strategy

Two New Studies Are Rewriting the Rules of Psychedelic Drug Development

Professional Training in Psychedelic Medicine

Psychedelic medicine is reshaping the future of mental health care. From the power of microdosing LSD to the promise of MDMA in PTSD, the world of medical psychedelics offers transformative possibilities. Our comprehensive, CE-accredited course provides you with the knowledge and understanding you need to tap into this groundbreaking field.

WordPress Ads

No Result

View All Result